456 Studies Now Enrolling
A Multicenter, Randomized, Parallel Group, Double-Blind, Multiple Dose, Placebo-Controlled Study to Assess the Efficacy and Safety of MNK-1411 in Male Subjects 4 to 8 Years of Age With Duchenne Muscular Dystrophy
Brave Trial, A Clinical Research Study for Duchenne Muscular Dystrophy (DMD)
| Sponsor: | Mallinckrodt |
| Enrolling: | Male Patients Only |
| Study Length: | 14 Months |
| IRB Number: | AAAR7151 |
| U.S. Govt. ID: | NCT03400852 |
| Contact: | Ameneh Onativia: 212-342-3679 / am2959@cumc.columbia.edu |
Additional Study Information:
Our clinic is currently participating in the Brave Trial, a clinical research study for Duchenne muscular dystrophy (DMD). This study is being conducted to learn whether a study drug can improve motor functions in boys with DMD. If your child takes part, he'll receive at no cost: study drug or placebo, study-related procedures, reimbursement for reasonable expenses.
This study is closed
